Getting to Know the New NICHD Director
NICHD Director Dr. Diana Bianchi shares some thoughts about joining NICHD.
News & Updates
NICHD issues Releases and Media Advisories to the news media. Science Updates and Spotlights explain NICHD research findings and public health issues to the general public. An Item of Interest is a short announcement such as an initiative launch or a notable staff change. Director’s Corner posts are monthly updates from the NICHD director.
Fat-cell storage altered in women with infertility disorder, small NIH-funded study suggests
Women with polycystic ovary syndrome (PCOS) may store fat differently than women who don’t have the common infertility disorder, according to a study funded by the National Institutes of Health.
Study to Offer Insight on the Adolescent Brain
NICHD joins other NIH Institutes in supporting a study that will collect brain imaging and other data to better understand teen behavior.
Federal agencies express support for updated safe infant sleep recommendations
Federal agencies concerned with infant health and welfare today announced their support of the American Academy of Pediatrics (AAP) updated recommendations on safe infant sleep.
Even partial steroid treatment can benefit extremely preterm infants, NIH study suggests
Steroids improve survival and reduce the chances of certain complications for extremely premature infants, even if the treatment course is not finished before delivery, according to a study funded by the National Institutes of Health (NIH).
Azithromycin pretreatment lowers infection rate after C-section, NIH-funded study finds
Treatment with the antibiotic azithromycin before an unplanned cesarean delivery reduces the post-operation infection rate by about 50 percent, compared to the standard treatment, according to a study funded by the National Institutes of Health. Results of the study appear in the September 29 issue of the New England Journal of Medicine.
Video: What is Clinical Research?
Clinical research occurs in many formats and can involve anyone. Learn how you can participate and contribute to medical advances.
NIH funds research network focused on HIV-infected youth
The National Institutes of Health has awarded funding for a research network devoted to the health and well-being of adolescents and young adults with HIV or at risk for HIV infection.
NIH study links morning sickness to lower risk of pregnancy loss
A new analysis by researchers at the National Institutes of Health has provided the strongest evidence to date that nausea and vomiting during pregnancy is associated with a lower risk of miscarriage in pregnant women.
Depression in early pregnancy linked to gestational diabetes, NIH study finds
Researchers at the National Institutes of Health have discovered a two-way link between depression and gestational diabetes. Women who reported feeling depressed during the first two trimesters of pregnancy were nearly twice as likely to develop gestational diabetes, according to an analysis of pregnancy records.
High fat, sugar diet during pregnancy may increase ADHD risk in offspring
A diet high in fat and sugar during pregnancy may interact with a gene that controls early brain development in the fetus, potentially increasing the risk for attention deficit hyperactive disorder (ADHD) in some individuals, according to a study funded by the National Institutes of Health.
Little Glands, Big Effects: Understanding and Treating Adrenal Gland Disorders
NICHD conducts and supports research to understand and ultimately treat adrenal gland disorders. Read how families and NICHD researchers work together to advance knowledge about these conditions.
Recruitment begins for landmark study of adolescent brain development
Recruitment for the Adolescent Brain Cognitive Development (ABCD (link is external)) study, the largest long-term study of brain development and child health in the United States, began today.
Podcast: Persistent delinquent behavior linked to early life setbacks
This is "Research Developments," a podcast from the NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development, the NICHD.
Extreme temperatures could increase preterm birth risk
Extreme hot or cold temperatures during pregnancy may increase the risk of preterm birth, according to study by researchers at the National Institutes of Health.
Infographic: Growing Up After Zika
NICHD investigates development throughout the entire life process, including fetal development and early childhood. This infographic describes what research so far has shown about Zika's impact on the developing brain.
NIH names Dr. Diana Bianchi director of the National Institute of Child Health and Human Development
National Institutes of Health Director Francis S. Collins, M.D., Ph.D., announced today the selection of Diana W. Bianchi, M.D., as director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD. Dr.Bianchi is expected to join NIH on Oct. 31, 2016.
New strategy holds promise for detecting bacterial infections in newborns
Researchers supported by NICHD have shown that it's possible to diagnose a bacterial infection, in infants with fevers who are 2 months of age or younger, by detecting the immune system's response to the bacteria in a small sample of blood.
NIH to host scientific workshop on Zika virus and child development
NICHD will host a workshop on September 22-23, 2016 to identify the best approaches for treating and caring for children exposed to Zika virus in the womb. Participants from the United States, Brazil and Puerto Rico, who are experts in obstetrics, maternal and pediatric infectious diseases, child development, rehabilitation and vaccine research, will deliver lectures and lead panel discussions.
Cholesterol drug appears beneficial for Smith-Lemli-Opitz syndrome
Simvastatin, commonly prescribed for reducing cholesterol, may be effective for treating Smith-Lemli-Opitz syndrome (SLOS), according to a new study from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health. The study is the first randomized, double-blinded, placebo-controlled trial of a statin drug for SLOS, a rare genetic disease that currently has no cure or approved treatment.
BACK TO TOP